Crossmark

Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding

Crossref DOI link: https://doi.org/10.1007/s10557-021-07170-6

Published Online: 2021-03-17

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, So-Ryoung

Kwon, Soonil

Choi, Eue-Keun https://orcid.org/0000-0002-0411-6372
Jung, Jin-Hyung

Han, Kyung-Do

Oh, Seil

Lip, Gregory Y. H.
Funding

Funding for this research was provided by:

The Korean government (202013B14)

The Korea National Research Foundation (2020R1F1A106740)
License Information

Text and Data Mining valid from 2021-03-17

Version of Record valid from 2021-03-17
More Information

Article History

Accepted: 1 March 2021

First Online: 17 March 2021

Declarations

:

: SRL, SK, JHJ, KDH, SO: None.EKC: Research grant from Sanofi-Aventis, Chong Kun Dang, Daiichi-Sankyo, BMS/Pfizer, Biosense Webster, and Skylabs.GYHL: Consultant for Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon, and Daiichi-Sankyo. Speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. No fees have been received personally.

Document is current

Any future updates will be listed below